Podcast Episode Details
Back to Podcast Episodes
Canada's Food Price Report Sneak Peek, Lefty Farmers, Campbell's Chicken Soup Traitor & guest Ransom Hawley, CEO of Caddle, on How GLP-1 Drugs Are Reshaping Canadians
Season 6 Episode 14
This episode of The Food Professor Podcast takes a deep dive into one of the most powerful forces now reshaping the food industry: the rapid rise of GLP-1 weight-loss drugs such as Ozempic and Wegovy. Hosts Michael LeBlanc and Dr. Sylvain Charlebois begin with a run-through of current food and retail headlines, including controversy at Campbell Soup, conversations around AI adoption and innovation in the food sector, and early teasers from the 2026 Canada Food Price Report. These stories set the stage for this week’s feature discussion: how GLP-1 medications are altering what consumers eat, where they shop, and which products they choose.
The heart of the episode features an in-depth interview with Ransom Hawley, Founder and CEO of Caddle, a Canadian mobile-first consumer insights platform with access to real-time behavioural data. Hawley shares new Canadian research showing GLP-1 household usage has jumped from 10% to 14% over two years, a dramatic 40% increase. Equally important is the shift in why people are taking these drugs: where most users initially relied on them to manage type-2 diabetes, an increasing number now use them primarily for weight loss. That consumer pivot mirrors rapid adoption trends in the United States and offers important clues about what’s coming next for Canadian retailers, manufacturers and restaurants.
Hawley reveals that GLP-1 users report eating less, losing weight, buying fewer groceries, and reducing restaurant visits. Consumption of alcohol, sugary beverages and impulse-driven snack foods is falling, while protein-rich foods, functional beverages and satiety-oriented products are gaining momentum. Categories seeing the steepest declines include bakery goods, packaged cookies, chocolates, soft drinks and sweet snacks—all long-time staples of convenience-driven food consumption. This suggests a structural shift, not a temporary fad.
The conversation expands to consider the broader implications. As GLP-1 usage rises, brands face new challenges and opportunities: How should they reformulate products for consumers who eat less? Should retailers redesign planograms to reflect category shrinkage? Will foodservice operators pivot toward protein-forward meals, smoothies and portion-smart menu strategies? As the hosts discuss, this is the first time since COVID-era lockdowns that such a large segment of the population is simultaneously changing eating behaviours, and its ripple effects will reshape category strategies, promotional plans, and innovation pipelines.
By the end of the episode, one thing is clear: GLP-1 drugs are not just a pharmaceutical phenomenon—they are transforming food culture, retail economics, and consumer expectations. Retailers and brands that ignore this shift risk falling behind; those who understand it may unlock a once-in-a-generation competitive advantage.
The Food Professor #podcast is presented by Caddle.
About Us
Dr. Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University. Before joining Dalhousie, he was affiliated with the University of Guelph’s Arrell Food Institute, which he co-founded. Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. Google Scholar ranks him as one of the world's most cited scholars in food supply chain management, food value chains and traceability.
He has authored five books on global food systems, his most recent one published in 2017 by Wiley-Blackwell entitled “Food Safety, Risk Intelligence and Benchmarking”
Published on 2 weeks, 2 days ago